J Korean Cancer Assoc.
1992 Aug;24(4):570-576.
Alternating non-cross-resistant chemotherapy with CAV(cyclophosphamide, adriamycin, vincristine) and EP(etoposide, cisplatin) in small cell lung cancer
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Alterating combination chemotherapy of cyclophosphamide, adriamycin, and vincristine(CAV) with etoposide and cisplatin(EP) in small cell lung cancer
- Combination chemotherapy with cyclophosphamide, vincristine, cisplatin, and etoposide(COPE) combined with radiotherapy for small cell lung cancer
- Effect Of Vpp/Cav Alternating Chemotherapy Versus Carboplatin/Etoposide(Ce) Chemotherapy For Extensive Stage Small Cell Lung Cancer
- Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer
- Treatment of Small Cell Lung Cancer
